GASTRO Flashcards

1
Q

Achalasia - Definition

A

Oesophageal motility disorder:

1) Loss of peristalsis
2) Failure of relaxation of the lower oesophageal sphincter (LOS).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Achalasia - Aetiology & Epidemiology

A

1) Ganglion cells of the myenteric plexus in the oesophagus degenerate - unknown cause.
2) More common in people with Oesophageal infection with Trypanosoma cruzi seen in Central/S. America produces a similar disorder (Chagas’ disease).

Epidemiology: Annual incidence is about 1 in 100,000. Usual presentation age: 25–60 years.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Achalasia - History

  • Presenting symptoms of achalasia…
  • Recognise the signs of achalasia on physical…
A

Insidious onset, gradual progression of:

1) intermittent dysphagia (difficulty swallowing) involving solids and liquids;
2) difficulty belching (burping);
3) regurgitation (particularly at night);
4) heartburn
5) chest pain (atypical/cramping, retrosternal);
6) weight loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Achalasia - Investigations

A

1) CXR - may show widened mediastinum and double right heart border (dilated oesophagus), an air-fluid level in the upper chest and absence of the normal gastric air bubble.
2) Barium swallow: Dilated oesophagus which smoothly tapers down to the sphincter (beak- shaped).
3) Endoscopy: To exclude malignancy which can mimic achalasia.
4) Manometry: A test used to measure the function of the lower esophageal sphincter (the valve that prevents reflux of gastric acid into the esophagus) and the muscles of the esophagus…
- Elevated resting LOS pressure (>45 mmHg);
- incomplete LOS relaxation;
- absence of peristalsis in the distal (smooth muscle portion) of the oesophagus.
5) Serology for antibodies against T. cruzi if Chagas’ disease is suggested by epidemiology and
symptoms. Blood film might detect parasites.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Achalasia - Management

& Complications & Prognosis

A

1) Pneumatic balloon dilation of the LOS: Up to 80% short-term success rate, 2–6% risk of oesophageal perforation.
2) Heller myotomy - surgery where LOS muscles cut, allowing food to pass to the stomach. Surgery can be complicated by reflux oesophagitis and some surgeons combine it with a fundoplication procedure to prevent reflux. Recently, laparoscopic/ thoracoscopic techniques to perform myotomy.
3) Botulinum toxin injected into the LOS inhibits acetylcholine release from the excitatory neurons that increase smooth muscle tone. The long-term safety/efficacy remain uncertain.
4) Medical treatment: Nitrates and calcium channel blockers (e.g. nifedipine) may be used to relax the smooth muscle of the LOS. Medical treatment is often ineffective, and may be associated with side effects (e.g. headache, hypotension) and tachyphylaxis.

COMPLICATIONS: If untreated, aspiration pneumonia (infection after inhaling vomit) , malnutrition and weight loss. 15 x risk of oesophageal malignancy, (on average 15 years after diagnosis).

PROGNOSIS: Good if treated. If untreated, oesophageal dilation may worsen causing pressure on mediastinal structures.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Coeliac disease - Definition

A

Inflammatory disease caused by intolerance to gluten, causing chronic intestinal malabsorption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Coeliac disease - Aetiology & Epidemiology

A

Sensitivity to the gliadin component of gluten, triggers an immunological reaction in the small intestine leading to mucosal damage and loss of villi. 10% risk of first-degree relatives being affected, clear genetic susceptibility associated with HLA-B8, DR3 and DQW2 haplotypes.

EPIDEMIOLOGY: UK prevalence is 1 in 2000. One in 300 in the west of Ireland; rare in East Asia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Coeliac disease - History

A

May be asymptomatic.
Abdominal discomfort, pain and distention.
Steatorrhoea (pale bulky stool, with offensive smell and difficult to flush away), diarrhoea.
Tiredness, malaise, weight loss (despite normal diet).
Failure to ‘thrive’ in children, amenorrhoea (absence of menstruation) in young adults.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Coeliac disease - Examination

A

1) Signs of anaemia: Pallor.
2) Signs of malnutrition: Short stature, abdominal distension and wasted buttocks in children.
3) Triceps skinfold thickness gives an indication of fat stores.
4) Signs of vitamin or mineral deficiencies (e.g. osteomalacia, easy bruising).
5) Intense, itchy blisters on elbows, knees or buttocks (dermatitis herpetiformis).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Coeliac disease - Investigations

A

1) Blood: FBC (low Hb), iron and folate, U&E, albumin, Ca2+ and phosphate.
2) Serology (blood serum): Testing for IgG anti-gliadin (AGA), IgA and IgG anti-endomysial transglutaminase antibodies can be diagnostic. As IgA deficiency is common (1 in 50 with coeliac disease) immunoglobulin levels should also be measured to avoid false negatives.
3) Stool: Culture to exclude infection, faecal fat tests for steatorrhoea.
4) D-xylose test: Reduced urinary excretion after an oral xylose load indicates small bowel malabsorption.
5) Endoscopy: Shows villous atrophy in the small intestine (particularly jejunum and ileum) mucosa looks flat and smooth. Biopsy shows villous atrophy with crypt hyperplasia of the duodenum. The epithelium adopts a cuboidal appearance, and there is an inflammatory infiltrate of lymphocytes and plasma cells in the lamina propria.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Coeliac disease - Management

A

Advice: Stop eating gluten, avoid all wheats, rye and barley. Expert dietary advice is essential.
Medical: Vitamin and mineral supplements. Oral corticosteroids if disease does not subside with gluten withdrawal.

C O M P L I C A T I O N S: Iron, folate and Vitamin B12 deficiency, osteomalacia (soft bones, Vit D/calcium def) , ulcerative jejunoileitis, gastrointestinal lymphoma (particularly T cell), bacterial overgrowth. Rarely, can cause cerebellar ataxia.

P R O G N O S I S: With strict adherence to gluten-free diet, most patients make a full recovery. Symptoms usually resolve within weeks. Histological changes may take longer to resolve. A gluten-free diet for life.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

X - NOT ON SOFIA. Colonic polyps - Definition

A

A protuberance into the lumen from the normally flat colonic mucosa.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

X- NOT ON SOFIA. Colonic polyps - Aetiology

A

Classified into neoplastic and non-neoplastic:
Neoplastic polyps include adenomas ( two-thirds of all colonic polyps) and adenocar-
cinomas.
Non-neoplastic polyps include hyperplastic polyps, inflammatory pseudopolyps (islands of
residual intact colonic mucosa resulting from mucosal ulceration and regeneration that occurs in inflammatory bowel disease), and hamartomatous polyps, e.g. in Peutz-Jeghers syndrome (autosomal dominant disorder associated with mucocutaneous pigmentation of lips and gums) and Cronkhite-Canada syndrome (associated with alopecia, nail atrophy, cutaneous hyperpigmentation and watery diarrhoea).
Multiple colonic polyps occur in familial adenomatous polyposis (FAP) and its variants such as Turcot’s syndrome (FAP associated with glioblastomas or medulloblastomas) and Gardner’s syndrome (FAP associated with osteomas, soft-tissue tumours, sebaceous cysts). These are autosomal dominant diseases caused by mutations in the adenomatous polyposis coli (APC) gene.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

X - NOT ON SOFIA. Colonic polyps - History & Exam

A

Usually asymptomatic.
May cause a change in bowel habit, tenesmus if in the rectum. Mucoid diarrhoea.
PR bleeding (in case of polyp ulceration).
Symptoms of anaemia.

EXAM: Usually no findings on examination. May be palpable on PR examination if low in rectum. Associated features of the syndromes mentioned above.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

X - NOT ON SOFIA
Colonic polyps - Investigations
& Management

A

Blood: FBC (look for microcytic anaemia).
Stool: Occult or frank blood in stool.
Endoscopy: Colonoscopy is the gold standard investigation. For multiple polyposis syn-
dromes, an upper GI endoscopy is necessary to look for upper GI polyps. Polyps removed need to be histologically examined to determine their malignant potential.

MANAGEMENT:
Colonoscopic polypectomy for small isolated polyps. Large polyps may have to be surgically resected. In multiple polyposis syndromes (particularly FAP), early colectomy is recommended to reduce risk of malignancy.
Follow-up: The timing of the next follow-up colonoscopy depends on the number, size and histology of polyps, family history, preferences of the patient and judgment of the physician. Guidelines suggest:
for 1–2 small (< 1 cm) tubular adenomas with low-grade dysplasia: 5 years;
for 3–10 adenomas, or any adenoma 1cm, with villous features, or high-grade dysplasia: 3 years;
for >10 adenomas: < 3 years;
for a large (>2 cm) sessile polyp: 2–6 months to ensure complete removal.
Genetic screening of relatives may be necessary in multiple polyposis syndromes.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Colorectal carcinoma - definition

A

Malignant adenocarcinoma of the large bowel.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Colorectal carcinoma - Aetiology

A

Environmental & genetic factors.
Epithelial dysplasia leading to adenoma (benign from glandular epith) and then carcinoma is thought to occur, involving accumulation of genetic changes in oncogenes (e.g. APC, K-ras) and tumour suppressor genes (e.g. p53, DCC).
- 60% in rectum & sigmoid colon
- 20% in the ascending colon
- Rest in transverse & descending
Chronic bowel inflammation (e.g. IBD) also increases the risk of
colorectal carcinoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Colorectal carcinoma - History

A

Symptoms depend on location of the tumour.
1) Left-sided colon and rectum: Change in bowel habit, rectal bleeding or blood/mucous mixed in with stools. Rectal masses may also present as tenesmus (sensation of incomplete
emptying after defecation).
2) Right-sided colon: Later presentation, with symptoms of anaemia, weight loss and non-specific malaise or, more rarely, lower abdominal pain.
3) Up to 20% of tumours will present as an emergency with pain and distension caused by large bowel obstruction, haemorrhage or peritonitis as a result of perforation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Colorectal carcinoma - Examination

A
  • Anaemia may be only sign, particularly in right-sided lesions.
  • Abdominal mass, low-lying rectal tumours may be palpable on rectal examination.
  • Metastatic disease: Hepatomegaly, ‘shifting dullness’ of ascites.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Colorectal carcinoma - Investigations

A

1) Blood: FBC (for anaemia), LFT, tumour markers (CEA to monitor treatment response or disease recurrence).
2) Stool: Occult or frank blood in stool (can be used as a screening test).
3) Endoscopy: Sigmoidoscopy, colonoscopy. Allows visualization and biopsy. Polypectomy can also be performed if isolated small carcinoma in situ.
4) Barium contrast studies: ‘Apple core’ stricture on barium enema. 5) Abdominal ultrasound scan for hepatic metastases.
6) Other staging investigations include CXR, CT or MRI, endorectal ultrasound.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Colorectal carcinoma - Management & Complications & Prognosis

A

Surgery: Surgery only curative treatment.

  • Caecum, ascending, proximal transverse colon: Right hemicolectomy.
  • Distal transverse colon, descending: Left hemicolectomy.
  • Sigmoid colon: Sigmoid colectomy.
  • High rectum: Anterior resection.
  • Low rectum: Abdo-perineal resection and end colostomy formation.
  • Emergency: Hartmann’s procedure (proximal colostomy, resection of tumour and oversew of distal stump).

Survival improved if total mesorectal excision (removal of surrounding fascia). Isolated hepatic metastases may be successfully resected.

Radiotherapy: May be given in a neoadjuvent setting to downstage rectal tumours prior to resection or as adjuvant therapy to reduce risk of recurrence.

Chemotherapy: Used as adjuvant therapy in Dukes’ C, or sometimes B. 5-Fluorouracil, oxaliplatin and irinotecan are common drugs in first-line chemotherapy protocols; newer agents like cetuximab (monoclonal against EGFR-receptor) and bevacizumab (monoclonal against VEGF) may be considered in metastatic disease or in the context of clinical trials.

COMPLICATIONS: Bowel obstruction or perforation, fistula formation. Recurrence. Metastatic disease.
PROGNOSIS: based on Dukes staging.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Crohn’s Disease - Definition

A

Chronic granulomatous inflammatory disease that can affect any part of the gastrointestinal tract. Grouped with ulcerative colitis and together they are known as inflammatory bowel disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Crohn’s Disease - Aetiology & Epidemiology

A

Unknown cause, genetic & environmental factors.
Inflammation occurs anywhere along GI tract (40% involving the terminal ileum) and ‘skip’ lesions with inflamed segments of bowel interspersed with normal segments is not unusual. CROHNS IS CRAY - hence it doesnt seem to have a pattern.

EPIDEMIOLOGY: Annual UK incidence is 5–8 in 100,000. Prevalence is 50–80 in 100,000. Affects any age but peak incidence is in the teens or twenties.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Crohn’s Disease - History

A

1) Crampy abdominal pain (caused by inflammation, fibrosis or bowel obstruction).
2) Diarrhoea (may be bloody or steatorrhoea).
3) Fever, malaise, weight loss.
4) Symptoms of complications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Crohn’s Disease - Examination

A

1) Weight loss, clubbing, signs of anaemia.
2) Aphthous ulceration of the mouth (igloo for life).
3) Perianal skin tags, fistulae and abscesses.
4) Signs of complications (eye disease, joint disease, skin disease).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Crohn’s Disease - Investigations

A

1) Blood: FBC (low Hb, high platelets, high WCC), U&E, LFTs ( low albumin), high ESR, CRP (high or may be normal), haematinics to look for deficiency states: ferritin, Vitamin B12 and red cell folate.

2) Stool microscopy and culture: To exclude infective colitis.
3) AXR: For evidence toxic megacolon.
4) Erect CXR: If risk of perforation.
5) Small bowel barium follow-through: May reveal fibrosis/strictures (string sign of Kantor), deep ulceration (rose thorn), cobblestone mucosa.
6) Endoscopy (OGD, colonoscopy) and biopsy:
- May help differentiate between UC & Crohn’s; monitors malignancy and disease progression.
- Mucosal oedema and ulceration with ‘rose-thorn’ fissures (cobblestone mucosa), fistulae, abscesses.
- Transmural chronic inflammation with infiltration of macrophages, lympho- cytes and plasma cells.
- Granulomas with epithelioid giant cells may be seen in blood vessels or lymphatics.
7) Radionuclide-labelled neutrophil scan: Localization of inflammation (when other tests are contraindicated).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Crohn’s Disease - Management

A

1) Acute exacerbation: Fluid resuscitation, IV or oral corticosteroids, 5-ASA analogues (e.g. mesalazine, sulfasalazine) may induce a remission. Analgesia. Elemental diet may induce remission (more often used in children). Parenteral nutrition may be necessary. Monitor markers of activity (fluid balance, ESR, CRP, platelets, stool frequency, Hb and albumin). Assess for complications.

2) Long term:
- Steroids: For treating acute exacerbations.
- 5-ASA analogues (e.g. sulfasalazine, mesalazine): # relapses. Useful for mild-to-moderate
disease.
- Immunosuppression: Using steroid-sparing agents (e.g. azathioprine, 6-mercaptopurine,
methotrexate) to # relapses.
- Anti-TNF agents (e.g. infliximab, adalimumab): Very effective agents in achieving and maintaining remission. Usually reserved for refractory cases.

3) Advice: Stop smoking, dietician advice.
4) Surgery: If above fails, failure to thrive in children or if complications. Affected bowel resected, stoma made. Risk of recurrence.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Crohn’s Disease - Complications & Prognosis

A

GI: Haemorrhage, bowel strictures, perforation, fistulae (between bowel, bladder, vagina), perianal fistulae and abscess, GI carcinoma (5% risk in 10 years), malabsorption.

Extraintestinal features: Uveitis, episcleritis, gallstones, kidney stones, arthropathy, sa- croiliitis, ankylosing spondylitis, erythema nodosum and pyoderma gangrenosum, amyloidosis.

PROGNOSIS: Chronic relapsing condition. Two-thirds will require surgery at some stage and two-thirds of these >1 surgical procedure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Diverticular disease - Definition

A
  • Diverticulae: outpouchings of colonic mucosa/submucosa throught muscular wall of large bowel.
  • Diverticulosis: presence of diverticulae
  • Diverticular disease: Diverticulosis associated with complications, e.g. haemorrhage, infection, fistulae.
  • Diverticulitis: Acute inflammation and infection of colonic diverticulae.

Hinchey classification of acute diverticulitis: Ia: phlegmon, Ib and II: localized abscesses,
III: perforation with purulent peritonitis or IV: faecal peritonitis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Diverticular disease - Aetiology & Epidemiology

A

Low-fibre diet= constipation. Thus, high colonic intraluminal pressures, herniation of mucosa and submucosa through the muscularis, particularly at sites of nutrient artery penetration.
Pathogenesis: Diverticulae most common in sigmoid and descending colon, but can be right sided. Absent from the rectum. Diverticulae get blocked by poop = bacterial overgrowth, toxin production and mucosal injury and diverticulitis, perforation, pericolic phlegmon, abscess, ulceration and fistulation or stricture formation.

EPIDEMIOLOGY: Common, 60% of people living in industrialized countries will develop colonic diverticula, rare < 40years. Right-sided diverticula are more common in Asia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Diverticular disease - History

A
Often asymptomatic (80–90%). 
Complications include: pr bleeding
Diverticulitis: typically, left iliac fossa or lower abdominal pain, fever. 
Diverticular fistulation into bladder: pneumaturia (gas in urine), faecaluria and recurrent UTI.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Diverticular disease - Examination

A

Diverticulitis: Tender abdomen; signs of local or generalized peritonitis if perforation has occurred.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Diverticular disease - Investigations

A

1) Bloods: FBC, high WCC & CRP in diverticulitis, check clotting and cross-match if bleeding.
2)Barium enema ( +/- air contrast): Demonstrates the presence of diverticulae with a saw- tooth appearance of lumen = pseudohypertrophy of circular muscle (not performed in acute setting as danger of perforation).
3) Flexible sigmoidoscopy and colonoscopy: Diverticulae can be seen and other pathology (e.g. polyps or tumour) can be excluded.
In an acute setting: CT scan for evidence of diverticular disease and complications.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Diverticular disease - Management, Complications & Prognosis

A

1) Asymptomatic: Soluble high-fibre diet (20–30 g/day). Probiotics and anti-inflammatories (mesalazine) are under investigation for preventing recurrent flares of diverticulitis.
2) GI bleed: PR bleeding is often managed conservatively with IV rehydration, antibiotics, blood transfusion if necessary. Angiography and embolization or surgery if severe.
3) Diverticulitis: Treated by IV antibiotics and IV fluid rehydration and bowel rest. Localized collections or abscesses may be treated by radiologically sited drains.

4) Surgery: May be necessary with recurrent attacks or when complications develop, e.g. perforation and peritonitis. Surgical treatment can be by open or laparoscopic approaches. Open: Hartmann’s procedure (resection and stoma) or one-stage resection and anastomosis (risk of leak) defunctioning stoma.
More recently, laparoscopic drainage, peritoneal lavage and drain placement can be effective.

COMPLICATIONS: Diverticulitis, pericolic abscess, perforation, faecal peritonitis, colonic obstruction, fistula formation (bladder, small intestine, vagina), haemorrhage.

PROGNOSIS: Ten to 25% of patients will have one or more episodes of diverticulitis. Of these, 30% will have a second episode.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Gall Stones- Definition

A

Acute Cholecystitis: Stone or sludge impaction in neck of gall bladder = continuous epigastric or RUQ pain. Referred to the right shoulder, vomiting, fever, local peritonism (shock, ab pain, tenderness, vom), or a GB mass. Main difference from biliary colic is the inflammatory compenent ( high WCC, peritonism, fever). If stone moves to the common bile duct, obstructive jaundice and cholangitis may occure.
{Biliary colic doesnt have jaundice or fever/high WCC, it is just pain. While cholangitis has pain, fever and jaundice.}

Chronic Cholecystitis: Chronic inflammation and colic. ‘Flatulent dyspepsia’: vague abdominal discomfort, distension, nausea, flatulence, fat intolerance (fat causes cholecystokinin release and GB contraction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Gall stones - Aetiology

A

Mixed stones: Contain cholesterol, calcium bilirubinate, phosphate and protein (80%). Associated with older age, female, obesity, parenteral nutrition, drugs (OCP, octreotide), family history, ethnicity (e.g. Pima Indians), interruption of the enterohepatic recirculation of bile salts (e.g. Crohn’s disease), terminal ileal resection.
Pure cholesterol stones (10%): Similar associations as mixed stones.
Pigment stones (10%): Black stones made of calcium bilirubinate (“ bilirubin secondary to haemolytic disorders, cirrhosis), brown stones due to bile duct infestation by liver fluke Clonorchis sinensis. Associated with haemolytic disorders (e.g. sickle cell, thalassemia,
hereditary spherocytosis).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Gall stones - History

A

(90% gallstones asymptomatic: Found incidentally.)

1) Acute Cholecystitis: Patient unwell, fever, prolonged continuous epigastric or RUQ pain, may be referred to right shoulder (due to diaphragmatic irritation). Vomiting, local peritonism (shock, ab pain, tenderness, vom), or a GB mass.

{Main difference from biliary colic is the inflammatory component ( high WCC, peritonism, fever). If stone moves to the common bile duct, obstructive jaundice and cholangitis may occur. {Cholangitis has pain, fever and jaundice.}

2) Ascending cholangitis: Classical association between right upper quadrant pain, jaundice and rigors (shiver even on fever) = (Charcot’s triad). If combined with hypotension and confusion, it is known as Reynold’s pentad.

3) Biliary colic: Sudden onset, severe right upper quadrant or epigastric pain, constant in nature. May radiate to right scapula, often precipitated by a fatty meal. Can last hours,
may be associated nausea and vomiting.
- Biliary colic doesnt have jaundice or fever/high WCC, it is just pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Gall stones - Examination

A

1) Acute cholecystitis: Tachycardia, pyrexia, right upper quadrant or epigastric tenderness.
There may be guarding rebound.
Murphy’s sign is elicited by placing a hand at the costal margin in the RUQ and asking the patient to breathe deeply. Patient stops breathing as the inflamed gallbladder descends and contacts the palpating fingers. (only positive if the same test on the left side doesn’t cause pain)
A phlegmon (RUQ mass of inflamed adherent omentum and bowel) may be palpable.

2) Ascending cholangitis: Pyrexia, right upper quadrant pain, jaundice.
3) Biliary colic: Right upper quadrant or epigastric tenderness.

39
Q

Gall stones - Investigations

A

Acute cholecystitis: high WCC; Ultrasound - thick walled, shrunken gall bladder, pericholecystic fluid, stones, CBD dilated (6mm plus), HIDA cholescintography useful if diagnosis uncertaim post US. Plain AXR only shows 10% of stones.

Chronic cholecystitis: US to image stones and assess CBD diameter. MRCP used to find CBD stones.

Stones: Bloods: FBC (high WBC in cholecystitis or cholangitis), LFT (high AlkPhos, high bilirubin in ascending cholangitis; there may be high transaminases), blood cultures, amylase (risk of pancreatitis). USS: Demonstrates gallstones (acoustic shadow within the gallbladder), high thickness of gallbladder wall and can examine for presence of dilatation of biliary tree indicative of
obstruction.
AXR: Gallstones are infrequently radio-opaque (10%).
Other imaging: Erect CXR (to exclude perforation as a differential diagnosis), CT scanning,
magnetic resonance cholangiopancreatography (MRCP) or endoscopic retrograde cho- langiopancreatography (ERCP).

40
Q

Gall stones - Management

A

Mild symptoms: Conservative, avoidance of fat in diet.

1) Acute Cholecystitis: NBM, pain relief. Laparoscopic cholecystectomy.

Chronic cholecystectomy: Cholecystectomy. If US shows dilated CBD with stones - ERCP + sphincterotomy before surgery.

2) Cholangitis: Treat with cefuroxime and metronidazole.

3) Severe biliary colic: IV fluids, analgesia, NBM, antiemetics and antibiotics if signs of infection (cholecystitis or cholangitis).
If symptoms fail to improve or worsen, a localized abscess or empyema should be suspected.
This can be drained percutaneously by cholecystostomy and pigtail catheter.
If there is evidence of obstruction, urgent biliary drainage by ERCP or percutaneous transhepatic cholangiogram.

Surgical: Laparoscopic cholecystectomy on table cholangiogram.
In acute setting, performed within 72 h of symptom onset, or after several weeks for inflammation to settle.
Stones within gallbladder: Biliary colic, cholecystitis, mucocoele or gallbladder empyema,
porcelain gallbladder, predisposition to gallbladder cancer (rare).

Stones outside gallbladder: Obstructive jaundice, pancreatitis, ascending cholangitis, perforation and pericholecystic abscess or bile peritonitis, cholecystenteric fistula, gall- stone ileus, Mirizzi syndrome (common hepatic duct obstruction by an extrinsic com- pression from an impacted stone in the cystic duct), Bouveret’s syndrome (gallstones causing gastric outlet obstruction).
Of cholecystectomy: Bleeding, infection, bile leak, bile duct injury (0.3% laparoscopic, 0.2% open), post-cholecystectomy syndrome (persistant dyspeptic symptoms), port-site hernias.

41
Q

Gastric Carcinoma - Definition

A

Gastric malignancy, most commonly adenocarcinoma, more rarely lympho- ma, leiomyosarcoma.

42
Q

Gastric Carcinoma - Aetiology

A

Most cases are probably caused by environmental insults in genetically predisposed individuals that lead to mutation and subsequent unregulated cell growth. Risk factors include:
. Helicobacter pylori infection;
. atrophic gastritis;
. diet high in smoked, processed foods and nitrosamines;
. smoking;
. alcohol.

43
Q

Gastric Carcinoma - History

A

In the early phases, it is often asymptomatic. Early satiety or epigastric discomfort.
Weight loss, anorexia, nausea and vomiting. Haematemesis, melaena, symptoms of anaemia. Dysphagia (tumours of the cardia).
Symptoms of metastases, particularly abdominal swelling (ascites) or jaundice (liver involvement).

44
Q

Gastric Carcinoma - Examination

A

Physical examination may be normal. Epigastric mass. Abdominal tenderness. Ascites.
Signs of anaemia.
Many eponymous signs:
Virchow’s node/Troisier’s sign: Lymphadenopathy in left supraclavicular fossa. Sister Mary Joseph node: Metastatic nodule on umbilicus.
Krukenberg’s tumour: Ovarian metastases.

45
Q

Gastric Carcinoma - Investigations

A

Upper GI endoscopy: With multiquadrant biopsy of all gastric ulcers. Blood: FBC (for anaemia), LFT.
CT/MRI: Staging of tumour and planning of surgery.
Ultrasound of liver: Staging of tumour.
Bone scan: Staging of tumour.
Endoscopic ultrasound: Assesses depth of invasion and lymph node spread. Laparoscopy: May be needed to determine if tumour is resectable.

46
Q

Gastric Carcinoma - Management

A

Surgery: Various surgical techniques, depending on size and tumour site.
Bilroth I partial gastrectomy: Excision of tumour and distal stomach. Duodenal stump is
anastomosed with remainder of stomach.
Bilroth II partial gastrectomy: Excision of tumour and distal stomach. Duodenal stump is
oversewn and remainder of the stomach is anastomosed to jejunum (gastrojejunostomy).
Suitable for antral tumours.
Total gastrectomy: Removal of stomach and spleen. Oesophagojejunostomy. Suitable for
large tumours.
Ivor–Lewis gastrectomy: Proximal gastrectomy and distal oesophagectomy, with
oesophagoantrostomy and pyloroplasty. Suitable for cardial or fundal tumours.
Roux-en-Y reconstruction: Duodenal stump oversewn. Distal duodenum anastomosed to jejunum.

47
Q

Gastroenteritis - Definition & Epidemiology

A

Acute inflammation of GI tract lining, manifested by nausea, vomiting, diarrhoea and abdominal discomfort.

EPIDEMIOLOGY: Common, and often under-reported, a serious cause of morbidity and mortality in the developing world.

48
Q

Gastroenteritis - Aetiology

A

Can be caused by viruses/ bacteria/ protozoa/ toxins in contaminated food/ water.

Viral: Rotavirus, adenovirus, astrovirus, calcivirus, Norwalk virus, small round structured viruses.

Bacterial: Campylobacter jejuni, Escherichia coli (particularly 0157), Salmonella, Shigella, Vibrio cholerae, Listeria, Yersinia enterocolitica.

Protozoal: Entamoeba histolytica, Cryptosporidium parvum, Giardia lamblia.

Toxins: From Staphylococcus aureus, Clostridium botulinum, Clostridium perfringens, Bacillus cereus, mushrooms, heavy metals, seafood.

Commonly contaminated foods: Improperly cooked meat (S. aureus, C. perfringens), old rice (B. cereus, S. aureus), eggs and poultry (Salmonella), milk and cheeses (Listeria,
Campylobacter), canned food (botulism).

Depending on the organism or toxin, there are different pathogenic mechanisms. Non-inflammatory mechanisms: e.g. V. cholerae, enterotoxigenic E. coli produce enter-
otoxins that cause enterocytes to secrete water and electrolytes.
Inflammatory mechanisms: e.g. Shigella, enteroinvasive E. coli release cytotoxins and invade and damage the epithelium, with greater invasion and bacteraemia in the case of Salmonella typhi.

49
Q

Gastroenteritis - History

A

Sudden onset nausea, vomiting, anorexia.
Diarrhoea (bloody or watery), abdominal pain or discomfort, fever and malaise.
Enquire about recent travel, antibiotic use and recent food intake (how cooked, source and whether anyone else ill).
Time of onset: Toxins (early; 1–24 h), bacterial/viral/protozoal (12 h or later).
Effect of toxin: Botulinum causes paralysis; mushrooms can cause fits, renal or liver failure.

50
Q

Gastroenteritis - Examination

A

Diffuse abdominal tenderness, abdominal distension and bowel sounds are often increased.
If severe, pyrexia, dehydration, hypotension, peripheral shutdown.

51
Q

Gastroenteritis - Investigations

A

1) Blood: FBC, blood culture (helps identification if bacteriaemia present), U&Es (dehydration).
2) Stool: Faecal microscopy for polymorphs, parasites, oocysts, culture, electron microscopy (used to diagnose viral infections). Analysis for toxins, particularly for pseudomembranous colitis (Clostridium difficile toxin).
3) AXR or ultrasound: To exclude other causes of abdominal pain.

Sigmoidoscopy: Often unnecessary unless inflammatory bowel disease needs to be
excluded.

52
Q

Gastroenteritis - Management

A

Bed rest, fluid and electrolyte replacement with oral rehydration solution (containing glucose and salt). IV rehydration may be necessary in those with severe vomiting. Most infections are self-limiting.

Antibiotic treatment is only warranted if severe or the infective agent has been identified (e.g. ciprofloxacin against Salmonella, Shigella, Campylobacter).
Cholera- Tetracycline
Salmonella, shigella, campylobacter - ciprofloxacin
Typhoid fever: See ‘Shorter topics’. Or if immunosuppressed or elderly, resistance common.
Botulism: Botulinum antitoxin IM and manage in ITU.
Public health: Often a notifiable disease. Educate on basic hygiene and cooking.

COMPLICATIONS: Dehydration, electrolyte imbalance, prerenal failure. Secondary lactose intolerance (particularly in infants). Sepsis and shock (particularly Salmonella and Shigella). Haemolytic uraemic syndrome is associated with toxins from E. coli 0157. Guillian–Barre syndrome may occur weeks after recovery from Campylobacter gastroenteritis.
Botulism: Respiratory muscle weakness or paralysis.

PROGNOSIS Generally good, as majority of cases self-limiting.

53
Q

Gastro-oesophageal reflux disease (GORD) - Definition & Epidemiology

A

Inflammation of the oesophagus caused by reflux of gastric acid and/or bile.

EPIDEMIOLOGY: Common, prevalence 5–10% adults. Increased in pregancy, obesity, smokers, large meals, after treatment of achalasia.

54
Q

Gastro-oesophageal reflux disease (GORD) - Aetiology

A

Disruption of mechanisms that prevent reflux (physiological LOS, mucosal rosette (folds of gastric mucosa) , acute angle of junction, intra-abdominal portion of oesophagus). Prolonged oesophageal clearance contributes to 50% of cases.

55
Q

Gastro-oesophageal reflux disease (GORD) - History

A
  • Substernal burning discomfort or ‘heartburn’ aggravated by lying supine, bending or large meals and drinking alcohol or hot drinks. Pain relieved by antacids.
  • Waterbrash (regurgitation of excessive saliva accumulation from lower part of oesophagus).
  • Regurgitation of gastric contents.
  • Aspiration may result in voice hoarseness, laryngitis, nocturnal cough and wheeze.
  • Aspiration pneumonia (rare).
  • Dysphagia (caused by formation of peptic stricture after long-standing reflux).
56
Q

Gastro-oesophageal reflux disease (GORD) - Examination

A

Usually normal. Occasionally, epigastric tenderness, wheeze on chest auscultation, dysphonia (difficulty speaking).

57
Q

Gastro-oesophageal reflux disease (GORD) - Investigations

A

1) Upper GI endoscopy, biopsy and cytological brushings: To confirm the presence of oesophagitis, exclude the possibility of malignancy (all patients >45 years).
2) Barium swallow: To detect hiatus hernia, peptic stricture, extrinsic compression of the oesophagus can be visualized.
3) CXR: Not specifically for GORD. Incidental finding of hiatus hernia (gastric bubble behind cardiac shadow).
4) Twenty-four hour oesophageal pH monitoring: pH probe placed in lower oesophagus determines the temporal relationship between symptoms and oesophageal pH.

58
Q

Gastro-oesophageal reflux disease (GORD) - Management

A

Advice: Lifestyle changes, weight loss, elevating head of bed, avoid provoking factors, stopping smoking, lower fat meals, avoiding large meals late in the evening.

Medical: Antacids and alginates, H2 antagonists (e.g. ranitidine) or proton pump inhibitors (e.g. lansoprazole) are sufficient for most patients.

Endoscopy: Annual endoscopic surveillance for Barrett’s oesophagus; may be necessary for stricture dilation or stenting.

Surgery: Anti-reflux surgery for those with symptoms despite optimal medical management or in those intolerant of medication.
Nissen fundoplication (fundus of the stomach is wrapped around the lower oesophagus and held with seromuscular sutures) helps reduce any hiatus hernia and reduce reflux.

COMPLICATIONS: Oesophageal ulceration, peptic stricture, anaemia, Barrett’s oesophagus and oesophageal adenocarcinoma. Associated with asthma and chronic laryngitis.

PROGNOSIS: 50% respond to lifestyle measures alone. In patients who require drug therapy withdrawal is often associated with relapse. 20% undergoing endoscopy for GORD have Barrett’s oesophagus.

59
Q

Irritable bowel syndrome (IBS) - Definition

A
Mixed group of abdominal symptoms for which no organic causes can be found. A functional bowel disorder defined as recurrent episodes (in the absence of detectable organic pathology) of abdominal pain/discomfort for 6 months of the previous year, associated with two of the following:
. altered stool passage;
. abdominal bloating;
. symptoms made worse by eating;
. passage of mucous.
60
Q

Irritable bowel syndrome - Aetiology & Epidemiology

A
Unknown. Probably due to disorders of intestinal motility or enhanced visceral perception. 
Psychosocial factors (particularly stress), food intolerance (e.g. lactose) are all implicated.

EPIDEMIOLOGY: Common, prevalence 10- 20% of adults. More common in women than men, 2:1 ratio.

61
Q

Irritable bowel syndrome - History

A

More than 6 month history abdominal pain (often colicky, in the lower abdomen and relieved by defecation or flatus).
Altered bowel frequency outside of 3 poos a day - 3 a week.
Abdominal bloating.
Change in stool consistency.
Passage with urgency or straining. Tenesmus (feeling like pooing with no actual poop)
Screen for ‘red flag’ alarm symptoms:
. weight loss;
. anaemia;
. PR bleeding;
. late onset ( 60 years).
Presence of any of the above requires referral to exclude colonic malignancy.

62
Q

Irritable bowel syndrome - Examination

A

Normally nothing on examination. In some cases the abdomen may appear distended and be mildly tender to palpation in one or both iliac fossa.

63
Q

Irritable bowel syndrome - Investigations

A

Diagnosis mainly from history but it may be vital to exclude organic pathology. Only diagnose IBS if abdominal pain/discomfort is relieved by defecation or associated with altered stool form or bowel frequency (constipation and diarrhea may alternate) AND if there are 2 of urgency; incomplete evacuation; abdominal bloating/distension; mucous PR; worsening of symptoms after food.

1) Blood: FBC (for anaemia), LFT, ESR, CRP, TFT. Anti-endomysial or anti-transglutaminase antibodies (to exclude coeliac disease).
2) Stool examination: Microscopy and culture for parasites, cysts and infection.
3) Ultrasound: To exclude gallstone disease.
4) Hydrogen breath test: To exclude dyspepsia associated with Helicobacter pylori.
5) Endoscopy: Upper GI endoscopy, sigmoidoscopy or colonoscopy if other pathologies suspected.

64
Q

Irritable bowel syndrome - Management, Complications & Prognosis

A

Advice: Explanation, support, positive doctor–patient relationship. Dietary modification (e.g. reducing dietary insoluble fibre) may help with constipation, other approaches include exclusion diets and use of probiotics.

Medical: According to the predominant symptoms:
. antispasmodics (e.g. mebeverin, buscopan);
. prokinetic agents (e.g. domperidone, metoclopramide);
. antidiarrhoeals (e.g. loperamide);
. laxatives (e.g. lactulose);
. low-dose tricyclic antidepressants (may decreased visceral awareness).

Psychological therapies: Often beneficial (e.g. cognitive–behavioural therapy, relaxation and psychotherapy).

  • see page 277 in Oxford for the holy grail.

COMPLICATIONS: Physical and psychological morbidity. Higher incidence of colonic diverticulosis.

PROGNOSIS: A chronic relapsing and remitting course, often exacerbated by psychosocial stresses.

65
Q

Ischaemic colitis - Definition & Epidemiology

A

Inflammation of the colon caused by decreased colonic blood supply.

EPIDEMIOLOGY: Most commonly in the elderly (60–80 years) with equal gender distribution.

66
Q

Ischaemic colitis - Aetiology

A

Occlusion of large vessels by thrombosis/embolism ( high risk with atherosclerosis, AF). Iatrogenic ligation (particularly AAA surgery). Hypovolaemia. In younger patients may be caused by small vessel vasculitis, vasospasm (e.g. cocaine) or hypercoagulable states.
No specific cause may be identified.

Ischaemia leads to mucosal inflammation, oedema, necrosis and ulceration. The splenic flexure, the watershed between superior and inferior mesenteric artery territories, is the most common area affected.

67
Q

Ischaemic colitis - History & Examination

A

Symptoms may be acute or chronic in onset.
Crampy abdominal pain, may be post-prandial (‘gut claudication’) giving ‘food fear’. Fever,
nausea, bloody diarrhoea.

EXAMINATION: There may be insufficient signs.
Abdominal distension and tenderness, local peritonism (worse on left).
Fever and tachycardia, depending on severity of insult.
Proctoscopy typically shows normal rectal mucosa with blood from a higher source.

68
Q

Ischaemic colitis - Investigations

A

Blood: FBC ( high WCC), high CRP, U&Es, LFTs, high LDH, high CK, high lactate, ABG (metabolic acidosis), clotting screen. Evaluation for hypercoagulability in younger patients and those with recurrent colonic ischemia.

Stool: Cultures for Salmonella, Shigella, Campylobacter, Yersinia, E. coli O157:H7, assay Clostridium difficile toxins (to exclude infective colitis).

AXR: Large bowel wall thickening or diffuse dilation, air in bowel wall, thumbprinting (submucosal oedema).

CXR (erect): Air under diaphragm in cases of perforation.

CT: Thickening of colonic wall, irregular lumen, intramural air, portal or mesenteric venous air, occlusion in larger blood vessels.

Colonoscopy: Usually without bowel preparation (to avoid reducing blood flow due to dehydration). May show: pale mucosa, petechial bleeding, bluish haemorrhagic nodules, cyanotic mucosa, mucosal friability and haemorrhagic ulcerations. Segmental distribution, abrupt transition between injured and non-injured mucosa and rectal sparing, favour ischemia rather than inflammatory bowel disease.

Angiography: May be normal or show attenuated flow or site of occlusion.

69
Q

Ischaemic colitis - Management

A

Conservative management: IV fluids, nil orally, broad-spectrum antibiotics that cover enteric bacteria (e.g. cephalosporin and metronidazole). Specific treatment of the cause of the vascular insufficiency. Nasogastric tube if an ileus is present. Cardiac function and oxygenation should be optimized.
Surgical: Colonic resection may be required in cases of gangrenous or perforated bowel.

Long term: Follow-up colonoscopy is used to assess recovery or stricture formation.

COMPLICATIONS: Acute ischaemia can lead to gangrene (15%), perforation, sepsis and, occasionally, toxic megacolon or pyocolon. Segmental ulcerating colitis, stricture formation with intestinal obstruction.

PROGNOSIS: Outcome depends on severity, extent and timing of ischaemic insult and comorbidities. The majority of cases settle with conservative measures.

70
Q

Acute Pancreatitis - Definition & Epidemiology

A

An acute inflammatory process of the pancreas with variable involvement of other regional tissues or remote organ systems.

Mild: Associated with minimal organ dysfunction and uneventful recovery.

Severe: Associated with organ failure and/or local complications such as necrosis, abscess or
pseudocyst.

EPIDEMIOLOGY: Common. Annual UK incidence 10/10000. Peak age is 60 years; in males, alcohol-induced is more common while in females, principal cause is gallstones.

71
Q

Acute Pancreatitis - Aetiology

A

Insult results in activation of pancreatic proenzymes within the duct/acini resulting in tissue damage and inflammation.
Most common: Gallstones, alcohol (80% cases).
Others: Drugs (e.g. steroids, azathioprine, thiazides, valproate), trauma, ERCP or abdom-
inal surgery, infective (e.g. mumps, EBV, CMV, coxsackie B, mycoplasma), hyperlipi- daemia, hyperparathyroidism, anatomical (e.g. pancreas divisum, annular pancreas), idiopathic.

72
Q

Acute Pancreatitis - History

A

Severe epigastric or abdominal pain (radiating to back, relieved by sitting forward, aggravated by movement).
Associated with anorexia, nausea and vomiting.
There may be a history of gallstones or alcohol intake.

73
Q

Acute Pancreatitis - Examination

A

Epigastric tenderness, fever. Shock, tachycardia, tachypnoea.
less Bowel sounds (due to ileus).
If severe and haemorrhagic, Turner’s sign (flank bruising) or Cullen’s sign (periumbilical
bruising).

74
Q

Acute Pancreatitis - Investigations

A

1) Bloods: high Amylase (usually >3 normal but does not correlate with severity), FBC (high WCC), U&Es, high glucose, high CRP, low Ca2+ , LFTs (maybe deranged if gallstone pancreatitis or alcohol), ABG (for hypoxia or metabolic acidosis).
2) USS: For gallstones or biliary dilatation.
3) Erect CXR: There may be pleural effusion. Mainly for excluding other causes.
4) AXR: To exclude other causes of acute abdomen. Psoas shadow may be lost.

5) CT scan: If diagnostic uncertainty or if persisting organ failure, signs of sepsis or deterioration
for severe cases. Scoring system (Balthazar score): combination of grade of pancreatitis and degree of necrosis.

75
Q

Acute Pancreatitis - Management

A

Assessment of severity: The two most validated scales are:
(1) Modified Glasgow combined with CRP (>210 mg/L).

(2) APACHE-II score
- Medical: Fluid and electrolyte resuscitation, urinary catheter and NG tube if vomiting. Analgesia and blood sugar control. Early HDU or intensive care support. Meta-analysis has shown reduced infective complications and mortality in severe pancreatitis with enteral, as opposed to parenteral, feeding. Prophylactic antibiotics have not been shown to reduce mortality, unless infective pancreatic necrosis develops.
- ERCP and sphincterotomy: For gallstone pancreatitis, cholangitis, jaundice or dilated common bile duct, ideally within 72 h. All patients should undergo definitive manage- ment of gallstones during same admission or within 2 weeks.
- Early detection and treatment of complications: e.g. if persistent symptoms and >30% pancreatic necrosis or signs of sepsis should undergo image guided fine needle aspiration for culture (BSG guidelines).
- Surgical: Patient with necrotizing pancreatitis should be managed in a specialist unit. Minimal access or open necresectomy (drainage and debridement of all necrotic tissue).

COMPLICATIONS:
Local: Pancreatic necrosis, pseudocyst (peripancreatic fluid collection persisting >4 weeks), abscess, ascites, pseudoaneurysm or venous thrombosis.
Systemic: Multiorgan dysfunction, sepsis, renal failure, ARDS, DIC, hypocalcemia, diabetes. Long term: Chronic pancreatitis (with diabetes and malabsorption).

PROGNOSIS:
20% follow severe fulminating course with high mortality (infected pancreatic necrosis associated with 70% mortality), 80% run milder course (but still 5% mortality).

76
Q

Chronic Pancreatitis - Definition

A

Chronic inflammatory disease of the pancreas characterized by irreversible parenchymal atrophy and fibrosis leading to impaired endocrine and exocrine function and recurrent abdominal pain.

77
Q

Chronic Pancreatitis - Aetiology & Epidemiology

A

Alcohol (70%). Idiopathic in 20%.

Rare: Recurrent acute pancreatitis, ductal obstruction, pancreas divisum, hereditary pan-
creatitis, tropical pancreatitis, autoimmune pancreatitis, hyperparathryroidism, hypertriglyceridemia.

EPIDEMIOLOGY: Annual UK incidence 1/ 100,000; prevalence 3/ 100,000. Mean age 40–50 years in alcohol-associated disease.

78
Q

Chronic Pancreatitis - History

A

Recurrent severe epigastric pain, radiating to back, relieved by sitting forward, can be exacerbated by eating or drinking alcohol. Over many years, weight loss, bloating and pale offensive stools (steatorrhoea).

79
Q

Chronic Pancreatitis - Exam

A

Epigastric tenderness. Signs of complications, e.g. weight loss, malnutrition.

80
Q

Chronic Pancreatitis - Pathology

A

Disruption of normal pancreatic glandular architecture due to chronic inflammation and fibrosis, calcification, parenchymal atropy, ductal dilatation, cyst and stone formation. Pancreatic stellate cells are thought to play a role, converting from quiescent fat storing cells to myofibroblast-like cells forming extracellular matrix, cytokines and growth factors in response to injury. Pain is associated with raised intraductal pressures and inflammation.

81
Q

Chronic Pancreatitis - Investigations

A

1) Bloods: Glucose ( raised may indicate endocrine dysfunction), glucose tolerance test. Amylase and lipase (usually normal), high immunoglobulins, especially IgG4 in autoimmune pancreatitis.
2) USS: Percutaneous or endoscopic: can show hyperechoic foci with post-acoustic shadowing.
3) ERCP or MRCP: Early changes include main duct dilatation and stumping of branches. Late manifestations are duct strictures with alternating dilatation (‘chain of lakes’ appearance).
4) AXR: Pancreatic calcification may be visible.
5) CT scan: Pancreatic cysts, calcification.
6) Tests of pancreatic exocrine function: Faecal elastase.

82
Q

Chronic Pancreatitis - Management, Complications & Prognosis

A

General: Treatment is mainly symptomatic and supportive, e.g. dietary advice, abstinence from alcohol and smoking, treatment of diabetes, oral pancreatic enzyme replacements, e.g. Creon, analgesia for exacerbations of pain. Chronic pain management may need specialist input. The sensory nerves to the pancreas transverse the coeliac ganglia and splanchnic nerves, coeliac plexus block (CT or EUS-guided neurolysis) and transthoracic splanchnicectomy offer variable degrees of pain relief.

Endoscopic therapy: Sphincterotomy, stone extraction, dilatation or stenting of strictures. Extracorporeal shock-wave lithotripsy is sometimes used for fragmentation of larger pancreatic stones prior to endoscopic removal.

Surgical: May be indicated if medical management has failed. Options include lateral pancreaticojejunal drainage (modified Puestow procedure), resection (pancreaticoduo- denectomy or Whipple’s) or limited resection of the pancreatic head (Beger procedure) or combined opening of the pancreatic duct and excavation of the pancreatic head (Frey procedure).

COMPLICATIONS: Local: Pseudocysts, biliary duct stricture, duodenal obstruction, pancreatic ascites, pancreatic carcinoma.

Systemic: Diabetes, steatorrhoea, reduced quality of life, chronic pain syndromes and dependence on strong analgesics.

PROGNOSIS:
Hard to predict as pain may improve, stabilize or worsen. Surgery improves symptoms in 60–70% but results are often not sustained. Life expectancy can be reduced by 10–20 years.

83
Q

Peptic Ulcer Disease - Definition

A

Ulceration of areas of the GI tract caused by exposure to gastric acid and pepsin. Most commonly gastric and duodenal (can also occur in oesophagus and Meckel’s diverticulum).

84
Q

Peptic Ulcer Disease - Aetiology & Epidemiology

A

Cause is an imbalance between damaging action of acid and pepsin and mucosal protective mechanisms. There is a strong correlation with Helicobacter pylori infection, but it is unclear how the organism causes formation of ulcers.

Common: Very strong association with H. pylori (present in 95% of duodenal and 70–80% of gastric ulcers), NSAID use.

Rare: Zollinger–Ellison syndrome.

EPIDEMIOLOGY:Common. Annual incidence is about 1–4/1000. More common in males. Duodenal ulcers have a mean age in the thirties, while gastric ulcers have a mean age in the fifties. H. pylori is usually acquired in childhood and the prevalence is roughly equivalent to age in years.

85
Q

Peptic Ulcer Disease - History

A

Epigastric abdominal pain: relieved by antacids. Symptoms have a variable relationship to food:
. if worse soon after eating, more likely to be gastric ulcers;
. if worse several hours later, more likely to be duodenal.

May present with complications (e.g. haematemesis, melaena).

86
Q

Peptic Ulcer Disease - Examination

A

May be no physical findings.
Epigastric tenderness.
Signs of complications (e.g. anaemia, succession splash in pyloric stenosis).

87
Q

Peptic Ulcer Disease - Investigations

A

1) Bloods: FBC (for anaemia), amylase (to exclude pancreatitis), U&Es, clotting screen (if GI bleeding), LFT, cross-match if actively bleeding. Secretin test; if Zollinger–Ellison syndrome is suspected: IV secretin causes a rise in serum gastrin in ZE patients but not controls.
2) Endoscopy: Four quadrant gastric ulcer biopsies to rule out malignancy; duodenal ulcers need not be biopsied.
3) Rockall scoring (see Gastrointestinal haemorrhage, upper): For severity after a GI bleed. Less than 3 carries good prognosis, >8 have a high risk of mortality.
4) Testing for H. pylori:

. 13C-Urea breath test: Radio-labelled urea given by mouth and detection of 13C in the expired air.

. Serology: IgG antibody against H. pylori, confirms exposure but not eradication.

. Stool antigen test. Campylobacter-like organism test: Gastric biopsy is placed with a substrate of urea and a pH indicator. If H. pylori is present, ammonia is produced from the
urea and there is a colour change (yellow to red).

5) Histology of biopsies: Difficult to visualize H. pylori so of limited value.

88
Q

Peptic Ulcer Disease - Management

A

1) Acute: Resuscitation if perforated or bleeding (IV colloids/crystalloids), close monitoring of vital signs, and proceeding endoscopic or surgical treatment.
Patients with upper GI bleeding should be treated with IV PPI (e.g. omeprazole or pantoprazole) at presentation until the cause of bleeding is confirmed. Patients with actively bleeding peptic ulcers or ulcers with high-risk stigmata (e.g. visible vessel or adherent clot) should continue IV PPI. Switch to oral PPI If there is no rebleeding within 24 hours.

2) Endoscopy: Haemostasis by injection sclerotherapy, laser or electrocoagulation.
3) Surgery: If perforated or ulcer-related bleeding cannot be controlled.
4) H. pylori eradication with ‘triple therapy’ for 1–2 weeks: Various combinations are recommended made up of one proton pump inhibitors and two antibiotics (e.g. clarithromycin þ amoxicillin, metronidazole þ tetracycline).
5) If not associated with H. pylori: Treat with PPIs or H2-antagonists. Stop NSAID use (especially diclofenac), use misoprostol (prostaglandin E1 analogue), if NSAID use is necessary.

COMPLICATIONS:
Rate of major complication is 1% per year including haemorrhage (haematemesis, melaena, iron-deficiency anaemia), perforation, obstruction/pyloric stenosis (due to scarring, penetration, pancreatitis).

PROGNOSIS: Overall lifetime risk 10%. Generally good as peptic ulcers associated with H. pylori can be cured by eradication.

89
Q

Ulcerative colitis - Definition

A

Chronic relapsing and remitting inflammatory disease affecting the large bowel.

90
Q

Ulcerative colitis - Aetiology & Epidemiology

A

Unknown. Suggested hypotheses include genetic susceptibility (chromosomes 12, 16), immune response to bacterial or self-antigens, environmental factors, altered neutrophil function, abnormality in epithelial cell integrity.
Positive family history of IBD ( 15%). Associated with raised serum pANCA, primary sclerosing cholangitis.

EPIDEMIOLOGY: Prevalence: 1/1500 (in developed world). Higher prevalence in Ashke- nazi Jews, Caucasians. Uncommon before the age of 10 years, peak onset age 20–40 years. Equal sex ratio up to age 40, then higher in males.

91
Q

Ulcerative colitis - History

A

Bloody or mucous diarrhoea (stool frequency related to severity of disease). Tenesmus and urgency. Crampy abdominal pain before passing stool, weight loss, fever. Symptoms of extra GI manifestations.

92
Q

Ulcerative colitis - Examination

A

Signs of iron-deficiency anaemia, dehydration. Clubbing. Abdominal tenderness, tachycardia. Blood, mucus and tenderness on PR examination. Signs of extra GI manifestations.

93
Q

Ulcerative colitis - Investigations

A

1) Bloods: FBC (low Hb, high WCC), high ESR or CRP, low albumin, cross-match if severe blood loss, LFT.
2) Stool: Culture as infectious colitis is a differential diagnosis. Faecal calprotectin – marker for disease severity.
3) AXR: To rule out toxic megacolon (see Toxic megacolon).

4) Flexible sigmoidoscopy or colonoscopy (and biopsy): Determines severity, histological
confirmation, detection of dysplasia.

5) Barium enema: Mucosal ulceration with granular appearance and filling defects (pseudo-
polyps) , featureless narrowed colon, loss of haustral pattern (leadpipe or hosepipe appearance). Colonoscopy and barium enema may be dangerous in acute exacerbations (risk of perforation).

94
Q

Ulcerative colitis - Management

A

1) Markers of activity: low Hb, low alb, high ESR or CRP and diarrhoea frequency (< 4 per day is mild, 4–6 per day is moderate, >6 per day is severe), bleeding, fever.
2) Acute exacerbation: IV rehydration, IV corticosteroids, antibiotics, bowel rest, parenteral feeding may be necessary, and DVT prophylaxis. Monitor fluid balance and vital signs closely. If toxic megacolon develops, low threshold for proctocolectomy and ileostomy as perforation has a mortality of 30%.

. Mild disease: Oral or rectal 5-aminosalicylic acid derivatives, e.g. sulphasalazine and/or rectal steroids.

. Moderate to severe disease: Oral steroids and oral 5-ASA. Immunosuppression with azathioprine, cyclosporine, 6-mercaptopurine, infliximab (anti-TNF monoclonal antibody).

3) Advice: Patient education and support. Treatment of complications. Regular colonoscopic surveillance.
4) Surgical: Indicated for failure of medical treatment, presence of complications or prevention of colonic carcinoma. Proctocolectomy with ileostomy or an ileo-anal pouch formation.

COMPLICATIONS:
Gastrointestinal: Haemorrhage, toxic megacolon, perforation, colonic carcinoma (in those with extensive disease for >10 years), gallstones and PSC.

Extra-gastrointestinal manifestations (10–20%): Uveitis, renal calculi, arthropathy, sacroiliitis, ankylosing spondylitis, erythema nodosum, pyoderma gangrenosum, osteo- porosis (from steroid treatment), amyloidosis.

PROGNOSIS: A relapsing and remitting condition, with normal life expectancy.

Poor prognostic factors (ABCDEF): Albumin (< 30 g/L), blood PR, CRP raised, dilated loops
of bowel, eight or more bowel movements per day, fever (>38C in first 24 h).